
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-24 of 24.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2011	Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients	Lesterhuis, W.J.; Vries, I.J.M. de; Schreibelt, G.; Lambeck, A.J.A.; Aarntzen, E.H.J.G.; Jacobs, J.F.M.; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Boer, A.J. de; Croockewit, S.; Rossum, M.M. van; Mus, R.D.M.; Oyen, W.J.G.; Boerman, O.C.; Lucas, S.; Adema, G.J.; Punt, C.J.A.; Figdor, Carl
2009	The Dutch vision of clinical pharmacology.	Schellens, J.H.; Grouls, R.; Guchelaar, H.J.; Touw, D.J.; Rongen, G.A.P.J.M.; Boer, A.J. de; Bortel, L.M. van
2009	In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.	Schuurhuis, D.H.; Verdijk, P.; Schreibelt, G.; Aarntzen, E.H.J.G.; Scharenborg, N.M.; Boer, A.J. de; Rakt, M.W.M.M. van de; Kerkhoff, M.M.A.; Gerritsen, M.J.P.; Eijckeler, F.D.J.; Bonenkamp, J.J.; Blokx, W.A.M.; Krieken, J.H.J.M. van; Boerman, O.C.; Oyen, W.J.G.; Punt, C.J.A.; Figdor, C.G.; Adema, G.J.; Vries, I.J.M. de
2006	Development of In-111-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination	Laverman, P.; Vries, I.J.M. de; Scharenborg, N.M.; Boer, A.J. de; Broekema, M.; Oyen, W.J.G.; Figdor, C.G.; Adema, G.J.; Boerman, O.C.
2006	Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests	Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Boullart, A.C.I.; Jacobs, J.F.M.; Boer, A.J. de; Scharenborg, N.M.; Brouwer, H.M.H.; Rakt, M.W.M.M.; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A.
2006	Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests.	Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Boullart, A.C.I.; Jacobs, J.F.M.; Boer, A.J. de; Scharenborg, N.M.; Brouwer, H.; Rakt, M.W.M.M. van de; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A.
2005	Vaccination of colorectal cancer patients with carcincembryonic antigen peptide-loaded dendritic cells	Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Scharenborg, N.M.; Brouwer, M.; Boer, A.J. de; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A.
2003	Analysis of dendritic cell trafficking using EGFP-transgenic mice	Eggert, A.A.O.; Voort, R. van der; Torensma, R.; Moulin, V.; Boerman, O.C.; Oyen, W.J.G.; Punt, C.J.A.; Diepstra, H.; Boer, A.J. de; Figdor, C.G.; Adema, G.J.
2000	Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model	Schreurs, M.W.J.; Eggert, A.A.O.; Boer, A.J. de; Vissers, J.L.M.; Hall, T. van; Offringa, R.; Figdor, C.G.; Adema, G.J.
1999	Generation and functional characterization of mouse monocyte-derived dendritic cells	Schreurs, M.W.J.; Eggert, A.A.O.; Boer, A.J. de; Figdor, C.G.; Adema, G.J.
1999	Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration	Eggert, A.A.O.; Schreurs, M.W.J.; Boerman, O.C.; Oyen, W.J.G.; Boer, A.J. de; Punt, C.J.A.; Figdor, C.G.; Adema, G.J.
1998	Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection	Schreurs, M.W.J.; Boer, A.J. de; Figdor, C.G.; Adema, G.J.
1997	Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100	Schreurs, M.W.J.; Boer, A.J. de; Schmidt, A.; Figdor, C.G.; Adema, G.J.
1996	pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL	Adema, G.J.; Bakker, A.B.H.; Boer, A.J. de; Hohenstein, P.; Figdor, C.G.
1995	Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro	Bakker, A.B.H.; Marland, G.; Boer, A.J. de; Huijbens, R.J.F.; Danen, E.H.J.; Adema, G.J.; Figdor, C.G.
1995	Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line	Bakker, A.B.H.; Schreurs, M.W.J.; Tafazzul, G.; Boer, A.J. de; Kawakami, Y.; Adema, G.J.; Figdor, C.G.
1994	Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes	Bakker, A.B.H.; Schreurs, M.W.J.; Boer, A.J. de; Kawakami, Y.; Rosenberg, S.A.; Adema, G.J.; Figdor, C.G.
1994	Molecular characterization of the melanocyte lineage-specific antigen gp100	Adema, G.J.; Boer, A.J. de; Vogel, A.M.; Loenen, W.A.M.; Figdor, C.G.
1993	Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA	Adema, G.J.; Boer, A.J. de; Hullenaar, R. van 't; Denijn, M.; Ruiter, D.J.; Vogel, A.M.; Figdor, C.G.
1993	Identification of the Melanoma Associated Antigens Recognized by Moabs Nki-Beteb and Hmb-45	Adema, G.J.; Boer, A.J. de; Vogel, A.M.; Figdor, C.G.
1993	Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction	Wiel-van Kemenade, E. van de; Ligtenberg, M.J.L.; Boer, A.J. de; Buijs, F.; Vos, H.L.; Melief, C.J.M.; Hilkens, J.; Figdor, C.G.
1993	Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer	Vlasveld, L.T.; Wiel-van Kemenade, E. van de; Boer, A.J. de; Sein, J.J.; Gallee, M.P.W.; Krediet, R.T.; Melief, C.J.M.; Rankin, E.M.; Hekman, A.; Figdor, C.G.
1992	Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the β subunit of VLA	Wiel-van Kemenade, E. van de; Kooyk, Y. van; Boer, A.J. de; Huijbens, R.J.F.; Weder, P.; Kasteele, W. van de; Melief, C.J.M.; Figdor, C.G.
1992	Both LFA-1 positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation	Wiel-van Kemenade, E. van de; Velde, A.A. te; Boer, A.J. de; Weening, R.S.; Fischer, A.; Borst, J.; Melief, C.J.M.; Figdor, C.G.